Results 11 to 20 of about 675,123 (288)

Somatostatin analogs: Future directions [PDF]

Metabolism, 1996
Herder, W.W. (Wouter) de, Hofland, L.J. (Leo), Lamberts, S.W.J. (Steven), Lely, A-J. (Aart-Jan) van der   +3 more
core   +4 more sources

Somatostatin analog therapy in delaying progression of polycystic liver disease: A meta-analysis with trial sequential analysis [PDF]

iLIVER
Background and aims: Polycystic liver disease (PLD) can occur independently or in association with autosomal dominant polycystic kidney disease and has no effective medical therapy.
Mohammed S. Beshr, Rana H. Shembesh, Bisher Sawaf, Shahem Abbarh, Mohammed Abu-Rumaileh, Monica Tincopa, Muhammed Elhadi   +6 more
doaj   +2 more sources

Synthetic somatostatin analogs beyond cancer. [PDF]

Pituitary
Barabutis N, Siejka A.
europepmc   +3 more sources

18F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use

Journal of Nuclear Medicine, 2023
Molecular imaging of the somatostatin receptor plays a key role in the clinical management of neuroendocrine tumors. PET imaging with somatostatin analogs (SSAs) labeled with 68Ga or 64Cu is currently the gold standard in clinical practice.
Hannes Leupe, S. Ahenkorah, Jeroen Dekervel, M. Unterrainer, E. Van Cutsem, C. Verslype, F. Cleeren, C. Deroose   +7 more
semanticscholar   +1 more source

Somatostatin analogs: is one better than other? [PDF]

Therapeutic Advances in Medical Oncology, 2017
Rossana Berardi, Stefano Partelli, Stefano Cascinu, Massimo Falconi   +3 more
doaj   +2 more sources

Somatostatin analog therapy effectiveness on the progression of polycystic kidney and liver disease: A systematic review and meta-analysis of randomized clinical trials.

PLoS ONE, 2021
BackgroundUncertainty underlies the effectiveness of somatostatin analogues for slowing the progression of polycystic kidney or liver disease.MethodsEligible studies included randomized controlled trials (RCTs) evaluating somatostatin analog as therapy ...
Tatsuya Suwabe, Francisco J Barrera, Rene Rodriguez-Gutierrez, Yoshifumi Ubara, Marie C Hogan   +4 more
doaj   +1 more source

Study Protocol of the PreFiPS Study: Prevention of Postoperative Pancreatic Fistula by Somatostatin Compared With Octreotide, a Prospective Randomized Controlled Trial

Frontiers in Medicine, 2021
Background: Pancreatic fistula (PF), i. e., a failure of the pancreatic anastomosis or closure of the remnant pancreas after distal pancreatectomy, is one of the most feared complications after pancreatic surgery.
Elisabeth Hain, Alexandre Challine, Stylianos Tzedakis, Alexandru Mare, Alessandro Martinino, David Fuks, Mustapha Adham, Guillaume Piessen, Jean-Marc Regimbeau, Emmanuel Buc, Louise Barbier, Jean-Christophe Vaillant, Florence Jeune, Laurent Sulpice, Fabrice Muscari, Lilian Schwarz, Sophie Deguelte, Antonio Sa Cunha, Stephanie Truant, Bertrand Dousset, Alain Sauvanet, Sébastien Gaujoux   +21 more
doaj   +1 more source

A transplantable phosphorylation probe for direct assessment of G protein-coupled receptor activation. [PDF]

PLoS ONE, 2012
The newly developed multireceptor somatostatin analogs pasireotide (SOM230), octreotide and somatoprim (DG3173) have primarily been characterized according to their binding profiles.
Andrea Kliewer, Anika Mann, Aline Petrich, Florian Pöll, Stefan Schulz   +4 more
doaj   +1 more source

Somatostatin venom analogs evolved by fish-hunting cone snails: From prey capture behavior to identifying drug leads

bioRxiv, 2021
Somatostatin (SS) is a peptide hormone with diverse physiological roles. By investigating a deep-water clade of fish-hunting cone snails, we show that predator-prey evolution has generated a diverse set of SS analogs, each optimized to elicit specific ...
I. B. Ramiro, Walden E. Bjørn-Yoshimoto, J. Imperial, J. Gajewiak, M. Watkins, Dylan Taylor, William Resager, B. Ueberheide, H. Bräuner‐Osborne, F. Whitby, C. Hill, Laurent F Martin, A. Patwardhan, G. Concepcion, B. Olivera, Helena Safavi-Hemami   +15 more
semanticscholar   +1 more source

Comparison between somatostatin analog injections

Revista da Associação Médica Brasileira, 2022
Long-acting depot formulations of somatostatin analogs, i.e., octreotide and lanreotide, are the first-line medical therapies for patients with acromegaly to whom surgery/radiotherapy cannot be performed or who have inadequate response. In this study, we aimed to evaluate the short-term local and systemic adverse reactions developed after the ...
Emre Gezer, Yeliz Demirhan, Alev Selek, Zeynep Cantürk, Berrin Çetinarslan, Mehmet Sözen, Damla Köksalan, Ayfer Peker Karatoprak   +7 more
openaire   +5 more sources